Patent · US Active

Compounds useful as serotonin inhibitors and 5-HT1A agonists and antagonists

US7495111B2 · kind B2 · utility

42Cited by
13References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2006
Grant dateFeb 24, 2009
Priority date
Expiry dateSep 9, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

3-Amino chroman and 2-amino tetralin derivatives and compositions containing such compounds are disclosed. Such compounds are useful for modulating activity of a 5-HT1A receptor (agonizing or antagonizing) in a patient. These compounds are further useful for inhibiting binding to a serotonin receptor. Methods of using the 3-amino chroman and 2-amino tetralin compounds and compositions containing such compounds in the treatment of serotonin disorders, such as depression and anxiety, are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.